
We need your help!
Your donation plays a critical role in our mission to advance herpes research, improve treatment options, and reduce stigma through education, outreach, and policy advocacy. By supporting us, you are helping to empower individuals with accurate information, advocate for better healthcare solutions, and fund promising therapies.
How Your Contribution Makes a Difference
With your generosity, we can:
- Drive Research for a Cure: Provide resources to move promising therapies from research stages into clinical trials, accelerating the path toward a herpes cure.
- Advance Vaccine Research: Support innovative research aimed at developing a herpes, a critical step in reducing transmission and long-term health impacts.
- Improve Testing and Diagnosis: Promote the development of faster, more accurate testing methods for early detection, helping to reduce transmission rates and improve outcomes.
- Advocate for Better Policy: Work with policymakers to develop policies that support herpes research, improve treatment options, and promote public health.
- Expand Awareness and Education: Educate the community to improve treatment outcomes, reduce stigma, and dispel common misconceptions about herpes through the creation and distribution of educational materials, conference resources, and partnerships for expert-led talks.
- Develop and Maintain Our Website: Maintain a reliable online platform where the community can access up-to-date information, resources, and support for herpes prevention and treatment.
Our Accomplishments
Click here to view list:
Thanks to the dedication of our supporters, we have achieved significant milestones in the fight to cure herpes, improve treatments, and raise awareness. Here are some of our recent accomplishments
2021: U.S. Congress includes a National Strategy and Strategic Plan for the Cure, Treatment, and Prevention of Herpes in the federal budget.
January 2022: Herpes Cure Advocacy (HCA) establishes itself as a tax-exempt 501(c)(3) non-profit organization in the USA.
November 2022: HCA co-hosts a joint CDC/NIH Workshop focused on herpes research and strategy.
December 2022: CDC issues a Request for Applications (RFA) for the development of improved HSV serology tests.
April 2023: The NIH forms a Multi-Council Working Group to coordinate efforts for a strategic approach to herpes research and treatment.
2023: NIH releases a comprehensive 5-year research strategy to advance herpes simplex virus (HSV) studies.
December 2023: Based on clinical and lab data provided by HCA, the FDA issues a safety communication regarding the limitations of herpes simplex virus antibody tests.
February 2024: The Office of the Assistant Secretary of Health releases a draft addendum to the National STI Strategy addressing herpes, with the final version published in November 2024.
Ongoing: HCA has successfully advocated for the CDC to assess the burden of neonatal herpes, initiating steps toward making it a nationally notifiable condition.
These milestones reflect our ongoing commitment to advancing herpes research, improving public health measures, and moving closer to a cure.
Transparency and Dedication
Our Board of Directors are dedicated volunteers who are committed to our cause.
Make a Difference Today
Your donation, no matter the amount, makes a real impact. Join us in our vision for a future where herpes is understood, effectively treated, and free from stigma. Thank you for your support!